Southpoint Capital Advisors LP Ocugen, Inc. Transaction History

Southpoint Capital Advisors LP

  • $3.57 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.83 - $3.45 $5.49 Million - $10.4 Million
-3,000,000 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$2.34 - $4.72 $3.85 Million - $7.77 Million
1,645,290 Added 121.45%
3,000,000 $9.9 Million
Q4 2021

Feb 14, 2022
BUY
$4.38 - $15.67 $5.93 Million - $21.2 Million
1,354,710 New
1,354,710 $6.16 Million

Others Institutions Holding OCGN

# of Institutions
124
Shares Held
78.3M
Call Options Held
535K
Put Options Held
523K
View Full List

About Ocugen, Inc.

OCGN Quotes by TradingView
  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $167M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Southpoint Capital Advisors LP Portfolio

Follow Southpoint Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Southpoint Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Southpoint Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email